MSB 2.03% $1.45 mesoblast limited

Undervalued Fair value $0.85, page-13

  1. 615 Posts.
    lightbulb Created with Sketch. 123
    I'm excited about the FDA news and looking to buy in. However looking at the financials, there was $77m in cash at 31 Dec 2023, which is enough cash to last until the end of 2024. Won't they need more investment to actually make the product ready for market? Where's that investment going to come from?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.